ACADIA PHARMACEUTICALS INC. (ACAD) Gross margin 2016–2025
ACADIA PHARMACEUTICALS INC. (ACAD) gross margin by fiscal year — reported gross profit divided by reported revenue.
91.7%FY2025 · since FY2016: 82.2% → 91.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 91.7% | +0.2 pp |
| FY2024 | 91.5% | -2.8 pp |
| FY2023 | 94.3% | -3.8 pp |
| FY2022 | 98.0% | +0.3 pp |
| FY2021 | 97.8% | +0.1 pp |
| FY2020 | 97.7% | +1.0 pp |
| FY2019 | 96.7% | +2.2 pp |
| FY2018 | 94.5% | +1.7 pp |
| FY2017 | 92.7% | +10.5 pp |
| FY2016 | 82.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ACAD financial trends
ACAD RevenueACAD Net incomeACAD Net marginACAD Gross profitACAD Operating incomeACAD Operating marginACAD Operating cash flowACAD Free cash flowACAD Capital expendituresACAD Return on equityACAD Stock buybacksACAD Dividends paidACAD Total assetsACAD Total liabilitiesACAD Shareholders’ equityACAD overview →